Silo Pharma's market cap is currently ―. The company's EPS TTM is $-1.206; its P/E ratio is -1.58; Silo Pharma is scheduled to report earnings on November 11, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 111.54K	$ -79.65K	$ 48.20K	$ 18.02K	$ 18.02K
Gross Profit	-	-	-	$ 16.57K	$ 16.57K
EBIT	-	$ 741.87K	$ -1.66M	$ -949.15K	$ -494.29K
EBITDA	-	$ 741.87K	$ -1.66M	$ -949.15K	$ -494.29K
Net Income Common Stockholders	$ -1.02M	$ -164.53K	$ -3.29M	$ -983.25K	$ -658.40K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 0.00	$ 0.00	$ 12.33M	$ 8.85M
Total Assets	$ 10.25M	$ 11.02M	$ 11.64M	$ 13.05M	$ 9.04M
Total Debt	$ 0.00	$ 660.28K	$ 364.22K	$ 0.00	$ 0.00
Net Debt	$ 0.00	$ 660.28K	$ 364.22K	$ -12.33M	$ -8.85M
Total Liabilities	$ 1.95M	$ 1.58M	$ 1.30M	$ 1.20M	$ 1.17M
Stockholders Equity	$ 8.30M	$ 9.44M	$ 10.34M	$ 11.85M	$ 7.87M
Cash Flow	-
Free Cash Flow	-	$ -692.69K	$ -885.99K	$ -1.42M	$ -400.11K
Operating Cash Flow	$ -549.97K	$ -692.69K	$ -885.99K	$ -1.42M	$ -400.11K
Investing Cash Flow	$ -3.83M	$ -6.01M	-	$ 0.00	$ 66.71K
Financing Cash Flow	$ -130.96K	-	-	$ 4.94M	$ 0.00

Currency in USD

Silo Pharma Earnings and Revenue History

Income Statement >

Silo Pharma Debt to Assets

Balance Sheet >

Silo Pharma Cash Flow

Cash Flow >

Silo Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing